Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis

Paediatric Respiratory Reviews

Volumn 12, Issue 2, 2011, Pages 97-103

  Chang, A B ^a   Byrnes, C A ^b   Everard, M L ^c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b THE UNIVERSITY OF AUCKLAND   (New Zealand)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Bronchiectasis; Children; Chronic lung disease; Diagnosis; Prevention; Suppurative lung disease

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BIOLOGICAL MARKER; BRONCHODILATING AGENT; PNEUMOCOCCUS VACCINE;

ASTHMA; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BIOFILM; BRONCHIECTASIS; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC SUPPURATIVE LUNG DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EARLY CHILDHOOD INTERVENTION; EARLY LIFE STRESS; ERADICATION THERAPY; FALSE POSITIVE RESULT; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFECTION PREVENTION; LOW BIRTH WEIGHT; LUNG CLEARANCE; LUNG DEVELOPMENT; LUNG DISEASE; LUNG EMPHYSEMA; MICROBIAL DEGRADATION; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; NONHUMAN; PATHOGENESIS; PEDIATRIC PHYSIOTHERAPY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTRACTED BACTERIAL BRONCHITIS; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SMOKING HABIT; SURVIVAL RATE;

ASTHMA; BRONCHIECTASIS; BRONCHITIS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; SUPPURATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953162759     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2010.10.008     Document Type: Review

References (76)

1. Chang A.B., Masel J.P., Boyce N.C., Wheaton G., Torzillo P.J. Non-CF bronchiectasis-clinical and HRCT evaluation. Pediatr Pulmonol 2003, 35:477-483.
2. Field C.E. Bronchiectasis in childhood: I. Clinical Survey of 160 Cases. Pediatrics 1949, 4:21-46.
3. Loebinger M.R., Wells A.U., Hansell D.M., et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009, 34:843-849.
4. Kapur N., Masters I.B., Chang A.B. Exacerbations in non cystic fibrosis bronchiectasis: Clinical features and investigations. Respir Med 2009, 103:1681-1687.
5. Svanes C., Sunyer J., Plana E., et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010, 64:14-20.
6. Goldsobel A.B., Chipps B.E. Cough in the pediatric population. J Pediatr 2010, 156:352-358.
7. Bush A. COPD: a pediatric disease. COPD 2008, 5:53-67.
8. Haidopoulou K., Calder A., Jones A., Jaffe A., Sonnappa S. Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol 2009, 44:669-675.
9. Chang A.B., Redding G.J., Everard M.L. State of the Art - Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr Pulmonol 2008, 43:519-531.
10. Donnelly D.E., Critchlow A., Everard M.L. Outcomes in Children Treated for Persistent Bacterial Bronchitis. Thorax 2007, 62:80-84.
11. Gupta S., Siddiqui S., Haldar P., et al. Qualitative Analysis of High Resolution Computed Tomography Scans in Severe Asthma. Chest 2009, 136:1521-1528.
12. Marchant J.M., Masters I.B., Taylor S.M., Cox N.C., Seymour G.J., Chang A.B. Evaluation and outcome of young children with chronic cough. Chest 2006, 129:1132-1141.
13. King P.T., Holdsworth S.R., Farmer M., Freezer N., Villanueva E., Holmes P.W. Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood. COPD 2009, 6:130-136.
14. Pasteur M.C., Helliwell S.M., Houghton S.J., et al. An Investigation into Causative Factors in Patients with Bronchiectasis. Am J Respir Crit Care Med 2000, 162:1277-1284.
15. Weycker D., Edelsberg J., Oster G., Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med 2005, 12:205-209.
16. Seitz A.E., Olivier K.N., Steiner C.A., De Oca R.M., Holland S.M., Prevots D.R. Trends and Burden of Bronchiectasis-Associated Hospitalizations: USA, 1993-2006. Chest 2010.
17. Twiss J., Metcalfe R., Edwards E.A., Byrnes C. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005, 90:737-740.
18. Wilson R., Dowling R.B., Jackson A.D. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J 1996, 9:1523-1530.
19. Slauson D.O., Hahn F.F. Criteria for development of animal models of diseases of the respiratory system: the comparative approach in respiratory disease model development. Am J Pathol 1980, 101:S103-S122.
20. McNeil C., Macgregor A.R., Alexander W.A. Studies of pneumonia in childhood: IV. Bronchiectasis and fibrosis of the lung. Arch Dis Child 1929, 4:170-189.
21. Silverman P.M., Godwin J.D. CT/bronchographic correlations in bronchiectasis. J Comput Assist Tomogr 1987, 11:52-56.
22. Young K., Aspestrand F., Kolbenstvedt A. High resolution CT and bronchography in the assessment of bronchiectasis. Acta Radiol 1991, 32:439-441.
23. Hill L.E., Ritchie G., Wightman A.J., Hill A.T., Murchison J.T. Comparison between conventional interrupted high-resolution CT and volume multidetector CT acquisition in the assessment of bronchiectasis. Br J Radiol 2010, 83:67-70.
24. Dodd J.D., Souza C.A., Muller N.L. Conventional high-resolution CT versus helical high-resolution MDCT in the detection of bronchiectasis. AJR Am J Roentgenol 2006, 187:414-420.
25. Roberts C.R., Pare P.D. Composition changes in human tracheal cartilage in growth and aging, including changes in proteoglycan structure. Am J Physiol 1991, 261:L92-101.
26. Rains J.K., Bert J.L., Roberts C.R., Pare P.D. Mechanical properties of human tracheal cartilage. J Appl Physiol 1992, 72:219-225.
27. Matsuoka S., Uchiyama K., Shima H., Ueno N., Oish S., Nojiri Y. Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. Am J Roentgenol 2003, 180:513-518.
28. Long F.R., Williams R.S., Castile R.G. Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 2004, 144:154-161.
29. Kapur N, Masel J P, Watson D, Masters I B, Chang A B. Bronchoarterial ratio on High Resolution CT scan of the chest in children without pulmonary pathology- Need to redefine bronchial dilatation. Chest 2010; Sep 23 [Epub ahead of print].
30. Brenner D.J. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol 2002, 32:228-231.
31. Gaillard E.A., Carty H., Heaf D., Smyth R.L. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol 2003, 47:215-220.
32. Field C.E. Bronchiectasis in childhood: II. Aetiology and Pathogenesis, Including a Survey of 272 Cases of Doubtful Irreversible Bronchiectasis. Pediatrics 1949, 4:231-248.
33. Nikolaizik W.H., Warner J.O. Aetiology of chronic suppurative lung disease. Arch Dis Child 1994, 70:141-142.
34. Bastardo C.M., Sonnappa S., Stanojevic S., et al. Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function. Thorax 2009, 64:246-251.
35. Chang A.B., Grimwood K., Mulholland E.K., Torzillo P.J. Bronchiectasis in Indigenous children in remote Australian communities. A position statement. Med J Aust 2002, 177:200-204.
36. Chang A.B., Grimwood K., Macguire G., King P.T., Morris P.S., Torzillo P.J. Management of bronchiectasis and chronic suppurative lung disease (CSLD) in Indigenous children and adults from rural and remote Australian communities. Med J Aust 2008, 189:386-393.
37. Chang A.B., Bell S.C., Byrnes C.A., et al. Bronchiectasis and chronic suppurative lung disease (CSLD) in children and adults in Australian and New Zealand: Thoracic Society of Australia and New Zealand and Australian Lung Foundation Position Statement. Med J Aust 2010, 193:356-365.
38. Kobayashi H. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. Treat Respir Med 2005, 4:241-253.
39. Hall-Stoodley L., Hu F.Z., Gieseke A., et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006, 296:202-211.
40. Steinfort D.P., Brady S., Weisinger H.S., Einsiedel L. Bronchiectasis in Central Australia: a young face to an old disease. Respir Med 2008, 102:574-578.
41. Kapur N., Masters I.B., Chang A.B. Longitudinal growth and lung function in pediatric non-CF bronchiectasis - what influences lung function stability?. Chest 2010, 138:158-164.
42. Kapur N., Karadag B. Differences and similarities in non-CF BE between developing and affluent countries. Paediatr Respir Rev 2011, 12:91-96.
43. Marchant J.M., Masters I.B., Taylor S.M., Chang A.B. Utility of signs and symptoms of chronic cough in predicting specific cause in children. Thorax 2006, 61:694-698.
44. Dharmage S.C., Erbas B., Jarvis D., et al. Do childhood respiratory infections continue to influence adult respiratory morbidity?. Eur Respir J 2009, 33:237-244.
45. Galobardes B., McCarron P., Jeffreys M., vey-Smith G. Medical history of respiratory disease in early life relates to morbidity and mortality in adulthood. Thorax 2008, 63:423-429.
46. Maritz G., Probyn M., De M.R., Snibson K., Harding R. Lung parenchyma at maturity is influenced by postnatal growth but not by moderate preterm birth in sheep. Neonatology 2008, 93:28-35.
47. Snibson K., Harding R. Postnatal growth rate, but not mild preterm birth, influences airway structure in adult sheep challenged with house dust mite. Exp Lung Res 2008, 34:69-84.
48. Balinotti J.E., Tiller C.J., Llapur C.J., et al. Growth of the lung parenchyma early in life. Am J Respir Crit Care Med 2009, 179:134-137.
49. Marchant J.M., Gibson P.G., Grissell T.V., Timmins N.L., Masters I.B., Chang A.B. Prospective assessment of protracted bacterial bronchitis: airway inflammation and innate immune activation. Pediatr Pulmonol 2008, 43:1092-1099.
50. Cowburn A.S., Condliffe A.M., Farahi N., Summers C., Chilvers E.R. Advances in neutrophil biology: clinical implications. Chest 2008, 134:606-612.
51. Gernez Y., Tirouvanziam R., Chanez P. Neutrophils in chronic inflammatory airway diseases: can we target them and how?. Eur Respir J 2010, 35:467-469.
52. Patel I.S., Vlahos I., Wilkinson T.M., et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400-407.
53. O'Brien C., Guest P.J., Hill S.L., Stockley R.A. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000, 55:635-642.
54. Meyers D.A., Larj M.J., Lange L. Genetics of asthma and COPD. Similar results for different phenotypes. Chest 2004, 126:105S-110S.
55. Valery P.C., Torzillo P.J., Mulholland E.K., Boyce N.C., Purdie D.M., Chang A.B. A hospital-based case-control study of bronchiectasis in Indigenous children in Central Australia. Pediatr Infect Dis J 2004, 23:902-908.
56. Tennant P.W.G., Gibson J.G., Pearce M.S. Lifecourse predictors of adult respiratory function: results from the Newcastle Thousand Families Study. Thorax 2008, 63:823-830.
57. Johnston I.D., Strachan D.P., Anderson H.R. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med 1998, 338:581-587.
58. Eren S., Esme H., Avci A. Risk factors affecting outcome and morbidity in the surgical management of bronchiectasis. J Thorac Cardiovasc Surg 2007, 134:392-398.
59. Martinez-Garcia M.A., Soler-Cataluna J.J., Perpina-Tordera M., Roman-Sanchez P., Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007, 132:1565-1572.
60. Twiss J., Stewart A.W., Byrnes C.A. Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis. Thorax 2006, 61:414-418.
61. Martinez-Garcia M.A., Perpina-Tordera M., Roman-Sanchez P., Soler-Cataluna J.J. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005, 128:739-745.
62. O'Byrne P.M., Lamm C.J., Busse W.W., Tan W.C., Pedersen S. The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009, 136:1514-1520.
63. Ellerman A., Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J 1997, 10:2376-2379.
64. Gharagozlou M., Ebrahimi F.A., Farhoudi A., et al. Pulmonary complications in primary hypogammaglobulinemia: a survey by high resolution CT scan. Monaldi Arch Chest Dis 2006, 65:69-74.
65. Priftis K.N., Mermiri D., Papadopoulou A., Anthracopoulos M.B., Vaos G., Nicolaidou P. The role of timely intervention in middle lobe syndrome in children. Chest 2005, 128:2504-2510.
66. Karadag B., Karakoc F., Ersu R., Kut A., Bakac S., Dagli E. Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration 2005, 72:233-238.
67. Ooi G.C., Khong P.L., Chan-Yeung M., et al. High-Resolution CT Quantification of Bronchiectasis: Clinical and Functional Correlation. Radiology 2002, 225:663-672.
68. Sheehan R.E., Wells A.U., Copley S.J., et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J 2002, 20:581-587.
69. Chang A.B., Bilton D. Non-cystic fibrosis bronchiectasis exacerbations. Thorax 2008, 63:269-276.
70. Chang C.C., Singleton R.J., Morris P.S., Chang A.B. Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database Syst Rev 2009, (Issue):2.
71. Anwar G.A., Bourke S.C., Afolabi G., Middleton P., Ward C., Rutherford R.M. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med 2008, 102:1494-1496.
72. Cymbala A.A., Edmonds L.C., Bauer M.A., et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med 2005, 4:117-122.
73. Reddel H.K., Taylor D.R., Bateman E.D., et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009, 180:59-99.
74. Hurst J.R., Wedzicha J.A. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med 2009, 7:40.
75. Loebinger M.R., Shoemark A., Berry M., Kemp M., Wilson R. Procalcitonin in stable and unstable patients with bronchiectasis. Chron Respir Dis 2008, 5:155-160.
76. Courtney J.M., Kelly M.G., Watt A., et al. Quality of life and inflammation in exacerbations of bronchiectasis. Chron Respir Dis 2008, 5:161-168.